You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

adverse-risk AML

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, Myelodysplastic Tumor Trial (Magrolimab, 7+3, CPX-351)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Neoplasm
  • (no location specified)
Apr 24, 2023

Adult Patients With Adverse Risk Acute Myeloblastic Leukemia Trial (Darzalex)

Not yet recruiting
  • Adult Patients With Adverse Risk Acute Myeloblastic Leukemia
  • (no location specified)
Feb 27, 2023

Acute Myeloid Leukemia Trial in Suzhou (Venetoclax Oral Tablet, Daunorubicin)

Recruiting
  • Acute Myeloid Leukemia
  • Suzhou, Jiangsu, China
  • +1 more
Jul 3, 2023

Acute Myeloid Leukemia Trial in France (Cytarabine and Idarubicin, CPX-315)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Amiens, France
  • +29 more
Apr 8, 2022

Acute Myeloid Leukemia Trial (ABBV-787)

Not yet recruiting
  • Acute Myeloid Leukemia
  • (no location specified)
Sep 29, 2023

Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Valhalla (Gemtuzumab Ozogamicin)

Active, not recruiting
  • Acute Myelogenous Leukemia
  • Myelodysplastic Syndrome
  • Gemtuzumab Ozogamicin
  • Valhalla, New York
    New York Medical College
Sep 26, 2022

Leukemia, Myeloid, Acute Trial in Chengdu (Chidamide)

Recruiting
  • Leukemia, Myeloid, Acute
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
Dec 27, 2022

Acute Myeloid Leukemia (AML), High-risk Myelodysplastic Syndrome (MDS) Trial in Worldwide (HDM201, MBG453, Venetoclax)

Active, not recruiting
  • Acute Myeloid Leukemia (AML)
  • High-risk Myelodysplastic Syndrome (MDS)
  • Durham, North Carolina
  • +8 more
Dec 13, 2022

AML, Adult Recurrent, MDS Trial in United States (LYT-200)

Recruiting
  • AML, Adult Recurrent
  • MDS
  • Los Angeles, California
  • +13 more
Apr 12, 2023

Leukemia, Myeloid, Acute Trial in Jerusalem (Vyxeos, Mylotarg)

Recruiting
  • Leukemia, Myeloid, Acute
  • Jerusalem, Yerushalayim, Israel
    Shaare Zedek Medical Center
Oct 25, 2022

Acute Myeloid Leukemia (AML) in Remission Trial in Suzhou (Azacitidine, Venetoclax, Supportive care)

Recruiting
  • Acute Myeloid Leukemia (AML) in Remission
  • Suzhou, Jiangsu, China
  • +1 more
Aug 18, 2022

Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Baltimore (Azacitidine, Sargramostim)

Completed
Has Results
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • Baltimore, Maryland
    The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sep 23, 2022

Adverse Drug Events Associated With Initiation of Drugs

Completed
  • COVID
  • +3 more
  • Simulation of Repurposed Drugs for COVID-19
  • Orlando, Florida
    Tabula Rasa HealthCare Precision Pharmacotherapy Research and De
Jan 30, 2023

Adverse Events and Change in Disease Activity in Participants

Recruiting
  • Acute Myeloid Leukemia (AML)
    • Seoul, Seoul Teugbyeolsi, Korea, Republic of
    • +5 more
    Nov 4, 2022

    Cardiac Tumor and Risk Stratification of Subsequent Adverse

    Not yet recruiting
    • Cardiac Tumor
      • Xi'an, Shaanxi, China
        First Affiliated Hospital of Xi'an Jiantong University
      Oct 19, 2023

      Leukemia, Acute Myeloid Leukemia, AML Trial in Tampa (Selinexor, Daunorubicin, Cytarabine)

      Completed
      • Leukemia
      • +2 more
      • Tampa, Florida
        H. Lee Moffitt Cancer Center and Research Institute
      Sep 30, 2022

      Acute Myeloid Leukemia Trial in Atlanta (Fludarabine, Melphalan, Pembrolizumab)

      Active, not recruiting
      • Acute Myeloid Leukemia
      • Atlanta, Georgia
      • +1 more
      Sep 7, 2022

      Acute Myelogenous Leukemia Trial in Rochester (Decitabine)

      Completed
      Has Results
      • Acute Myelogenous Leukemia
      • Rochester, New York
        University of Rochester
      Jul 1, 2022

      Coronary Artery Disease Trial in Sacramento (device, behavioral, other)

      Recruiting
      • Coronary Artery Disease
      • LiveCare
      • +2 more
      • Sacramento, California
        University of California, Davis Medical Center Division of Cardi
      Oct 27, 2023

      Haploidentical Stem Cell Transplantation, Conditioning Trial in Xi'an (MA-BUCY2, BUCY2)

      Not yet recruiting
      • Haploidentical Stem Cell Transplantation
      • Conditioning
      • Xi'an, Shaanxi, China
        First Affiliated Hospital of Xian Jiaotong University
      Apr 14, 2023

      Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Duarte (procedure, drug, biological, other)

      Not yet recruiting
      • Acute Myeloid Leukemia
      • Myelodysplastic Syndrome
      • Allogeneic Hematopoietic Stem Cell Transplantation
      • +8 more
      • Duarte, California
        City of Hope Medical Center
      Apr 10, 2023

      Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome Trial in Japan, United States (ASP7517)

      Active, not recruiting
      • Acute Myeloid Leukemia (AML)
      • Myelodysplastic Syndrome
      • ASP7517
      • Duarte, California
      • +15 more
      Jan 19, 2023

      Adverse Events After Head and Neck Vascular Recanalization

      Completed
      • Machine Learning
      • observe
      • Xi'an, Shaanxi, China
        Tangdu Hospital
      Nov 2, 2023

      Adverse Airway Events in High Risk Patients Undergoing Upper GI

      Active, not recruiting
      • SEDLine
      • +3 more
        • Philadelphia, Pennsylvania
          Hospital of the University of pennsylvania
        Nov 28, 2022

        Acute Myeloid Leukemia, Adult Trial in Suzhou (venetoclax combined with decitabine)

        Unknown status
        • Acute Myeloid Leukemia, Adult
        • venetoclax combined with decitabine
        • Suzhou, Jiangsu, China
          The First Affiliated Hospital of Soochow University, Jiangsu Ins
        Nov 8, 2021